Medication Access Guide

Medication Access Guide aims to assist clinicians in determining access to medications. Guide provides Information on available avenues including but not limited to: Patient Assistance Programs (through manufacturer), prescription copay cards, free trial cards and retail pharmacies offering discounted rates.

Analgesia [PDF] – last reviewed June 15, 2020

Antiasthmatic and Bronchodilator Agents [PDF] – last reviewed May 26, 2021

Cardiology  [PDF] – last reviewed June 15, 2020
  • Angiotension Converting Enzyme (ACE) Inhibitors | Angiotension Receptor Blockers (ARB)
  • Antiarrhythmics
  • Anticoagulants
  • Antiplatelets
  • Beta Blockers
  • Calcium Channel Blockers (CCB)
  • Diuretics
  • Nitrates
  • Statins
  • Combination Products
  • Miscellaneous

Endocrinology [PDF] – last reviewed February 4, 2022
  • Biguanides
  • Dipeptidyl Peptidase-4 (DPP4) Inhibitors
  • Glucagon Like Peptide-1 Receptor (GLP1) Agonists
  • Glucose Monitoring Supplies
  • Insulins
  • Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
  • Sulfonylureas
  • Thiazolidinediones (TZD)
  • Thyroid Medications
  • Combination Products

Gastroenterology [PDF] – last reviewed March 2, 2022
  • Antiemetics
  • Proton Pump Inhibitors (PPI)
  • Stool Softeners
  • Miscellaneous

Infectious Disease [PDF] – last reviewed April 5, 2022
  • Antibiotics
  • Antifungals
  • Antiparasitic
  • Antiretroviral Therapy (ART)
  • Antiviral Therapy
  • Immunosupression

Nephrology [PDF] – last reviewed April 22, 2022

Psychiatry/Neurology [PDF] – last reviewed May 12, 2022
  • ADD and ADHD Medications
  • Anticonvulsants
  • Antidepressants (Miscellaneous)
  • Antipsychotics
  • Selective Serotonin Reuptake Inhibitors (SSRI)
  • Serotonin and Norepinephrine Reuptake Inhibitors (SNRI)
  • Tricyclic Antidepressants (TCA)
  • Miscellaneous
​
Urology [PDF] – last reviewed April 22, 2022

Vitamins and Supplements [PDF] – last reviewed June 15, 2020
Back to Physician Forum COVID-19 main page
Physician Forum